Tatva Chintan Pharma Chem Limi

BSE: 543321 29 Sep 2025

Commodities

₹ 1062.2

Tatva Chintan Pharma Chem Limited specializes in Specialty Chemicals within the Commodities sector.

Tatva Chintan Pharma Chem Limi

BSE: 543321 29 Sep 2025

Commodities

₹ 1062.2

Tatva Chintan Pharma Chem Limited specializes in Specialty Chemicals within the Commodities sector.

Book Value

316.0

Dividend Yield

0.1%

Debt to Equity

0.05

Stock P/E

330.0

Market Cap

2,364 Cr

Tatva Chintan Pharma Chem Limi - Share Price & Details

Market Cap

₹2,364

High /Low

1,233 / 610.0

Stock P/E

330.0

Book Value

₹316.0

Dividend Yield

0.1

ROCE

1.2

ROE

₹0.78

Face Value

10.0

PEG Ratio

-5.42

EVEBITDA

₹57.9

Debt

36.4

CMP / FCF

-27.6

Debt to equity

₹0.05

NP Ann

5.71

High price all time

2,978

Piotroski score

₹5.0

Graham Number

147.0

No. Eq. Shares

2.34

Net CF

₹-23.9

Net profit

7.16

Price to book value

3.2

Interest Coverage

₹8.11

Low price all time

610.0

Industry PE

33.6

Reserves

₹715

Free Cash Flow

₹-51.5

Broker Recommendations

Date	Author	Type	Reco Price	Target Price	Potential	Source	PDF Link
03 Sep 2025	Deven Choksey	Sell	₹1,050.5	₹860	-19.7%	moneycontrol	View
08 May 2025	ICICI Securities	Buy	₹708.4	₹1,000	30.9%	moneycontrol	View
30 Jan 2025	KRChoksey	Sell	₹775.4	₹761	-3.7%	moneycontrol	View
28 Oct 2024	KRChoksey	Sell	₹818.55	₹809	-7.9%	moneycontrol	View
30 Jul 2024	KRChoksey	Hold	₹999.6	₹1,021	16.5%	moneycontrol	View
25 Jul 2024	ICICI Securities	Buy	₹991.7	₹1,850	111.1%	moneycontrol	View

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
SOUTHERN GAS LTD.	NA	NA	NA	NA	0.06	0.03
INDO GULF INDUSTRIES LTD.	NA	NA	NA	NA	0
Tatva Chintan Pharma Chem Limi	1105.49	51.33	1091.8	2.19	2,364	330.0
INSECTICIDES (INDIA) LTD.	6948.39	581.05	6911.33	19.97	2214	14.7
DECCAN GOLD MINES LTD.	NA	NA	NA	NA	2069

Peer Comparison Chart

About Tatva Chintan Pharma Chem Limi

Tatva Chintan Pharma Chem Limited, with Security Code 543321, is a leading player in the Specialty Chemicals industry, categorized under the Commodities sector, offering Equity instruments.

Order Book

Latest News

Tatva Chintan Pharma Chem - Goldman Sachs India portfolio slips, but 5 stocks rally 50-100% in 5 months

(11 Sep 2025)

The stock increased 51% in FY26 till now, from Rs 677 to Rs 1021. Goldman Sachs India's stake is approximately 2.59%, valued at Rs 62 crore.

Can Tatva Chintan Pharma Chem Limited (543321) Maintain Its Valuation - Real-time trading signals for maximum returns

(06 Aug 2025)

Can Tatva Chintan Pharma Chem Limited (543321) Maintain Its Valuation ✌️【Stock Analysis】✌️ Our expert forecasting and real-time tracking...

Quarterly Table

Standalone Consolidated

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Jun 2025
Sales	113.5	119.4	106.1	92.6	86.1	93.9	93.8	81.0	84.0	109.2
Expenses	96.7	104.0	86.5	71.8	73.8	79.7	86.1	76.4	78.4	94.1
Operating Profit	16.8	15.4	19.6	20.7	12.3	14.2	7.7	4.6	5.6	15.1
OPM %	14.84%	12.9%	18.48%	22.41%	14.31%	15.12%	8.2%	5.68%	6.72%	13.8%
Other Income	1.1	-2.8	1.0	0.8	1.2	4.5	1.4	0.8	0.0	1.4
Interest	2.4	3.2	2.9	3.0	0.4	0.2	0.3	0.2	0.4	0.4
Depreciation	2.4	2.5	6.0	6.8	6.6	6.2	6.7	6.8	6.9	9.0
Profit before tax	13.2	10.5	11.7	11.7	6.6	12.3	2.1	-1.6	-1.7	7.1
Tax %	-19.7%	134.5%	-29.6%	-29.9%	-29.1%	-32.8%	-29.4%	-29.5%	-29.5%	27.2%
Net Profit	10.6	16.2	8.2	8.2	4.7	8.2	1.5	-1.1	-1.2	5.1
EPS in Rs	4.76	7.29	3.72	3.63	1.99	3.52	0.64	-0.47	-0.5	2.19

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	120.6	124.5	114.4	96.7	84.2	98.3	105.5	83.5	85.9	107.9
Expenses	102.7	108.2	93.0	76.4	73.2	82.7	92.8	77.9	78.8	98.9
Operating Profit	17.9	16.3	21.3	20.2	11.0	15.6	12.6	5.6	7.1	9.0
OPM %	14.85%	13.07%	18.66%	20.95%	13.06%	15.88%	11.96%	6.69%	8.22%	8.35%
Other Income	1.5	-2.7	1.0	0.8	1.2	4.5	1.2	0.4	0.0	0.7
Interest	2.8	3.2	2.9	3.0	0.4	0.2	0.3	0.2	0.4	0.4
Depreciation	2.4	2.5	6.0	6.8	6.6	6.2	6.7	6.8	6.9	7.3
Profit before tax	14.2	11.4	13.4	11.2	5.2	13.7	6.8	-1.0	-0.2	2.1
Tax %	-18.3%	117.3%	-29.2%	-30.6%	-34.1%	-29.8%	23.5%	35%	158.7%	-44.4%
Net Profit	11.6	17.0	9.5	7.8	3.5	9.6	5.2	-0.7	0.1	1.0
EPS in Rs	5.24	7.65	4.29	3.43	1.48	4.11	2.23	-0.29	0.06	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	0%
5 Years:	8%
3 Years:	-5%
TTM:	-3%

Compounded Profit Growth
10 Years:	0%
5 Years:	-61%
3 Years:	-85%
TTM:	-99%

Stock Price CAGR
10 Years:	0%
5 Years:	0%
3 Years:	-25%
1 Year:	-18%

Compounded Sales Growth
10 Years:	0%
5 Years:	8%
3 Years:	-4%
TTM:	-3%

Compounded Profit Growth
10 Years:	0%
5 Years:	-31%
3 Years:	-61%
TTM:	-81%

Stock Price CAGR
10 Years:	0%
5 Years:	0%
3 Years:	-25%
1 Year:	-18%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Stock Mutual Funds Data

Order Book

News Date ▲▼	Headline ▲▼	Issuer Entity ▲▼	Issuer Type ▲▼	Order Size ▲▼	Time Period ▲▼
Loading company updates…

Loading technicals…

Moving Averages

Latest Close: — • Records Used: — • Last Trading Date: —

Simple Moving Averages (SMA)

Period	SMA Value	Status

Exponential Moving Averages (EMA)

Period	EMA Value	Status

Oscillators

Key Oscillators

latest calculation

Indicator	Value

Tatva Chintan Pharma Chem Limi

Tatva Chintan Pharma Chem Limi

Tatva Chintan Pharma Chem Limi - Share Price & Details

Broker Recommendations

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About Tatva Chintan Pharma Chem Limi

Order Book

Latest News

Tatva Chintan Pharma Chem - Goldman Sachs India portfolio slips, but 5 stocks rally 50-100% in 5 months

Sell Tatva Chintan Pharma Chem; target of Rs 860: Deven Choksey

Tatva Chintan Pharma Chem to hold AGM

Tatva Chintan to Hold AGM on September 26, 2025; Declares ₹1 Dividend

Tatva Chintan Announces Virtual AGM for September 2025

Can Tatva Chintan Pharma Chem Limited (543321) Maintain Its Valuation - Real-time trading signals for maximum returns

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Tatva Chintan Pharma Chem Achieves 52-Week High Amid Market Volatility

Here's why Tatva Chintan Pharma shares surged 20% on Friday in a weak market

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) most bullish insider is Senior Key Executive Ajaykumar Patel, and their holdings value went up by 10% last week

Macro Trends and Their Impact on Tatva Chintan Pharma Chem Limited (TATVA) - Lightning-fast capital gains

Where Could Tatva Chintan Pharma Chem Limited (543321) Be Headed - Free Stock Market Real-Time Monitoring

Can Tatva Chintan Pharma Chem Limited (543321) Maintain Its Valuation - Rapid wealth multiplication

Can Tatva Chintan Pharma Chem Limited (TATVA) Maintain Its Valuation - High-velocity gains

Tatva Chintan Pharma Chem Ltd leads gainers in 'B' group

बाजार में भारी बिकवाली के बीच यह स्टॉक 20% चढ़ा, मुकुल अग्रवाल ने भी लगाया है पैसा

Technical Analysis: Tatva Chintan Pharma Chem Limited (TATVA) - Rapidly expanding wealth

Tatva Chintan Pharma Chem Faces Ongoing Challenges Amid Mixed Financial Performance

Tatva Chintan Pharma Chem Limited (543321)’s Trend in 2025 - Exceptional financial outcomes

Can Tatva Chintan Pharma Chem Limited (543321) Maintain Its Valuation - High-yield investments

Tatva Chintan Pharma Chem Share Price Soars 12% After Mukul Agrawal Buys Stake

Mukul Agrawal buys stake in this underperforming IPO, sends stock soaring

Tatva Chintan Pharma Chem Shows Strong Short-Term Gains Amid Broader Market Decline

Tatva Chintan Pharma Chem Share Price Jumps 12% As Mukul Agrawal Picks Stake

Tatva Chintan Pharma Chem Experiences Mixed Technical Trends Amid Ongoing Financial Challenges

Tatva Chintan Pharma shares in focus after CRISIL downgrades ratings on bank facilities

Tatva Chintan Pharma Chem Shows Mixed Technical Trends Amid Market Volatility

Tatva Chintan Pharma Chem Shows Mixed Technical Trends Amid Market Evaluation Revision

Tatva Chintan Pharma Chem Faces Declining Profitability Amidst Market Challenges

Here are top 5 stocks that see heavy buying in today’s weak market - Market News

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) P/S Is Still On The Mark Following 25% Share Price Bounce

Here are top 5 stocks that see heavy buying in today’s weak market

Tatva Chintan Pharma Chem Shows Strong Intraday Gains Amid Mixed Market Sentiment

Briefs: Tatva Chintan Pharma Chem and Shelter Pharma

Buy Tatva Chintan Pharma Chem; target of Rs 1,000: ICICI Securities

Orient Bell Ltd leads gainers in 'B' group

TATVA CHINTAN PHARMA CHEM WINS EXPORT ORDER OF USD 35 55 000

Specialty Chemicals Company Bags Order Worth Rs 29,95,00,000 From An International Client

Tatva Chintan Pharma Chem reports consolidated Q4 FY25 PAT at Rs. 1.03 Cr

Tatva Chintan Pharma slides as Q4 PAT drops 89% YoY to Rs 1 cr

Tatva Chintan Consolidated March 2025 Net Sales at Rs 107.86 crore, up 9.77% Y-o-Y

Tatva Chintan Pharma Chem Reports Mixed Financial Results Amid Profitability and Liquidity Challenges in March 2025

Tatva Chintan Pharma Chem consolidated net profit declines 89.28% in the March 2025 quarter

Tatva Chintan Pharma Chem Faces Ongoing Challenges Amid Significant Stock Volatility

Tatva Chintan Pharma Chem Faces Significant Volatility Amid Broader Chemicals Sector Decline

Tatva Chintan Pharma Chem Faces Significant Decline Amid Ongoing Financial Struggles

Revenues Tell The Story For Tatva Chintan Pharma Chem Limited (NSE:TATVA)

Tatva Chintan Pharma Chem Faces Significant Volatility Amid Broader Chemicals Sector Struggles

Tatva Chintan Pharma Chem Gains 9.59% on January 3, 2025, Outperforming Sector

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Senior Key Executive Ajaykumar Patel is the most upbeat insider, and their holdings increased by 11% last week

IPO listing: Kronox Lab Sciences share price debuts at ₹165, a 21% premium to issue price

Nazara Tech, Sadbhav Engineering among 10 cos that saw highest drop in mutual fund holdings in Sept

Tatva Chintan Pharma Chem's Stock Sees 7.45% Increase, Outperforms Sector by 7.35%

Phase Transfer Catalyst Market Next Big Thing| Major Giants Tatva Chintan Pharma Chem, Central Drug House, Solvay

FIIs losing faith? 87 stocks see reduced stakes over last 4 quarters, 7 plummet 20-55% in 1 year

Reduce Tatva Chintan Pharma Chem; target of Rs 809: KR Choksey

Tatva Chintan Pharma Chem's Stock Plummets, Receives 'Strong Sell' Rating from MarketsMOJO

Tatva Chintan Consolidated September 2024 Net Sales at Rs 83.49 crore, down 13.63% Y-o-Y

Tatva Chintan Pharma Chem hits 52-week low, receives 'Strong Sell' rating from MarketsMOJO

Tatva Chintan Standalone September 2024 Net Sales at Rs 80.96 crore, down 12.54% Y-o-Y

Tatva Chintan Pharma Chem Second Quarter 2025 Earnings: Misses Expectations

Tatva Chintan Pharma Chem's Q2 FY25 Financial Results Show Negative Trends, Receives 'Strong Sell' Rating

Tatva Chintan Pharma Chem Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024

Tatva Chintan Pharma Chem Hits 52-Week Low, Receives 'Strong Sell' Rating from MarketsMOJO

Tatva Chintan Pharma Chem's Q3 Financial Results Show Negative Trends, Receives 'Strong Sell' Rating

Tatva Chintan Pharma Chem reports consolidated net loss of Rs 0.66 crore in the September 2024 quarter

Stocks to buy: Anand Rathi recommends these two stocks as its Emerging Picks for October | Stock Market News

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Underperforming IPOs: 5 public issue that were subscribed over 100x but are trading below listing price